Ledger.Open graph →
SEC Form D · filed August 20, 2019

Checkmate Pharmaceuticals, Inc

Offering
$16.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Habib Y. Gorgi · San Francisco, CADirectorTimothy Murphy · Des Moines, IAExecTerraForm Ventures IV LLC · Midvale, UTDirectorJack Honour · Las Vegas, NVExec · DirectorC. R. Mullet · Reston, VADirectorBrendan Keating · Las Vegas, NVExec · DirectorDonald P. Martin · Reston, VAExecClifford K. Holekamp · St. Louis, MODirectorDavid A. Smoller · St. Louis, MODirectorJon Lieber · Marlborough, MAExecArthur Reidel · San Martin, CADirectorAhmad Atwan · New York, NYDirectorAndrew Medvedev · New York, NYDirectorJames Wilmott · New York, NYExecSteve Berman · Atlanta, GAExec · DirectorSimeon Z. George, M.D · Solana Beach, CAExecPaul L. Hoffmann · Monona, WIExec · DirectorJarrid Tingle · Brooklyn, NYDirectorHenk LLC Air U.S. Life Fund I GP · CHICAGO, ILDirectorJon Lieber · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗